Sami Corwin
Stock Analyst at William Blair
(4.76)
# 612
Out of 4,596 analysts
414
Total ratings
53.8%
Success rate
17.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $1.88 | - | 27 | Jul 29, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | n/a | $7.30 | - | 12 | Jul 27, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | n/a | $9.51 | - | 17 | Jul 24, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | n/a | $341.12 | - | 19 | Jul 22, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $32.89 | - | 24 | Jun 29, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $31.88 | - | 10 | Jun 10, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | n/a | $47.99 | - | 19 | Jun 4, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $2.68 | - | 27 | Jun 3, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $8.06 | - | 19 | May 13, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $24 → $32 | $25.52 | +25.39% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $22.07 | -15.04% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.86 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.11 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $60.02 | - | 13 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.01 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.91 | - | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $43.63 | - | 29 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7403 | - | 15 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $18.55 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.09 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.02 | - | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.17 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.86 | n/a | 4 | Feb 1, 2023 |
Allogene Therapeutics
Jul 29, 2026
Maintained: Buy
Price Target: n/a
Current: $1.88
Upside: -
Kyverna Therapeutics
Jul 27, 2026
Maintained: Buy
Price Target: n/a
Current: $7.30
Upside: -
Zevra Therapeutics
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $9.51
Upside: -
Krystal Biotech
Jul 22, 2026
Maintained: Buy
Price Target: n/a
Current: $341.12
Upside: -
Neurogene
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $32.89
Upside: -
Tyra Biosciences
Jun 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.88
Upside: -
CRISPR Therapeutics AG
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $47.99
Upside: -
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $2.68
Upside: -
Solid Biosciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $8.06
Upside: -
Beam Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $24 → $32
Current: $25.52
Upside: +25.39%
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $22.07
Upside: -15.04%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.86
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $3.11
Upside: -
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $60.02
Upside: -
Feb 20, 2026
Maintained: Buy
Price Target: n/a
Current: $68.01
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: n/a
Current: $24.91
Upside: -
Feb 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $43.63
Upside: -
Jan 9, 2026
Maintained: Buy
Price Target: n/a
Current: $0.7403
Upside: -
Nov 12, 2025
Maintained: Hold
Price Target: n/a
Current: $18.55
Upside: -
Nov 11, 2025
Maintained: Hold
Price Target: n/a
Current: $2.09
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $2.02
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $14.17
Upside: n/a
Feb 1, 2023
Maintained: Buy
Price Target: n/a
Current: $5.86
Upside: n/a